The Department of Biochemistry, Faculty of Medicine, Universiti Kebangsaan Malaysia, Bandar Tun Razak, Kuala Lumpur 56000, Malaysia.
Department of Pharmacology, Faculty of Medicine, Universiti Teknologi MARA, Sg Buloh 47000, Malaysia.
Int J Mol Sci. 2024 Aug 29;25(17):9399. doi: 10.3390/ijms25179399.
Preclinical research on diabetes and obesity has been carried out in various animal models over the years. These animal models are developed from genetic manipulation that affects their body metabolism, chemical-induced procedures, diet alteration/modifications, or combinations of the aforementioned approaches. The diabetic and obesity animal models have allowed researchers to not only study the pathological aspect of the diseases but also enable them to screen and explore potential therapeutic compounds. Besides several widely known complications such as macrovascular diseases, diabetic neuropathy, nephropathy and retinopathy, type 2 diabetes mellitus is also known to affect bone health. There is also evidence to suggest obesity affects bone health. Therefore, continuous research needs to be conducted to find a remedy or solution to this matter. Previous literature reported evidence of bone loss in animal models of diabetes and obesity. These findings, as highlighted in this review, further augment the suggestion of an inter-relationship between diabetes, obesity and bone loss.
多年来,糖尿病和肥胖症的临床前研究一直在各种动物模型中进行。这些动物模型是通过影响其身体代谢的基因操作、化学诱导程序、饮食改变/修改或上述方法的组合开发的。糖尿病和肥胖动物模型不仅使研究人员能够研究疾病的病理方面,还使他们能够筛选和探索潜在的治疗化合物。除了几种众所周知的并发症,如大血管疾病、糖尿病神经病变、肾病和视网膜病变外,2 型糖尿病还已知会影响骨骼健康。有证据表明肥胖也会影响骨骼健康。因此,需要持续进行研究,以找到解决这一问题的方法。以前的文献报道了糖尿病和肥胖动物模型中骨丢失的证据。正如本综述所强调的那样,这些发现进一步增加了糖尿病、肥胖症和骨丢失之间存在相互关系的观点。